Most cited papers from Tartis (United States)

Tartis (United States)

What are the most cited papers from Tartis (United States)?

The most cited paper from Tartis (United States) is "p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs" (Katerina I. Leonova, Leonid Brodsky, Brittany C. Lipchick et al., 2012), with 273 citations. Next come "BMAL1-dependent regulation of the mTOR signaling pathway delays aging" (216) and "Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice" (151).

Published FieldAccessCitations

Showing 8 of 8 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs Katerina I. Leonova, Leonid Brodsky, Brittany C. Lipchick et al. · Proceedings of the National Academy of Sciences Open access	10 Dec 2012	273
2	BMAL1-dependent regulation of the mTOR signaling pathway delays aging Rohini V. Khapre, Anna A. Kondratova, Sonal A. Patel et al. · Aging Open access	29 Jan 2014	216
3	Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice Elena A. Komarova, Marina P. Antoch, Liliya R. Novototskaya et al. · Aging Open access	29 Oct 2012	151
4	New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis Maria Comas, Ilia A. Toshkov, Karen K. Kuropatwinski et al. · Aging Open access	29 Oct 2012	116
5	High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4) Leanna Cheung, Claudia L. Flemming, Fujiko Watt et al. · Biochemical Pharmacology Open access	25 Jun 2014	71
6	Sumoylation of Vimentin354 Is Associated with PIAS3 Inhibition of Glioma Cell Migration Liming Wang, Jian Zhang, Sipra Banerjee et al. · Oncotarget Open access	11 Nov 2010	45
7	Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice Maria Comas, Karen K. Kuropatwinski, Michelle M. Wrobel et al. · Chronobiology International Open access	16 Jun 2014	15
8	Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82 Susana Sarai Najera et al. · Molecular Cancer Therapeutics Open access	12 Oct 2024	12

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.